Krt14-CreERT2
모델명
C57BL/6Smoc-Krt14em2(CreERT2-Wpre-polyA)Smoc
카탈로그
NM-KI-190024
모델 상태
Repository Live
유전자 요약
Official Symbol
Krt14
모델 설명
검증 데이터
Fig1 CreERT2-mediated recombination in Skin, Tongue & Esophagus of Krt14 CreERT2+/-;R26 tdTomato+/- mice.
A， Krt14-CreERT2+/- ; Rosa26 tdTomato+/- ; Tamoxifen
B， Krt14-CreERT2+/-; Rosa26 tdTomato+/-
C， Rosa26 tdTomato+/-
Fig2 Confocal images showing expression of tdTomato in Skin, Tongue & Esophagus of Krt14 CreERT2+/-;R26 tdTomato +/- mice.
A， Krt14-CreERT2+/- ; Rosa26 tdTomato+/- ; Tamoxifen
B， Krt14-CreERT2+/-; Rosa26 tdTomato+/-
C， Rosa26 tdTomato+/-
간행물
A novel lineage of osteoprogenitor cells with dual epithelial and mesenchymal properties govern maxillofacial bone homeostasis and regeneration after MSFL
References：Cell Research
Pharmacological inhibition of MYC to mitigate chemoresistance in preclinical models of squamous cell carcinoma
References：Theranostics
당신은 또한 좋아할 수 있습니다
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
조회At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
조회